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Abstract
Background: Patients started on long term hemodialysis have typically had low rates of reported renal recovery with
recent estimates ranging from 0.9–2.4% while higher rates of recovery have been reported in cohorts with higher
percentages of patients with acute renal failure requiring dialysis.
Study Design: Our analysis followed approximately 194,000 patients who were initiated on hemodialysis during a 2-
year period (2008 & 2009) with CMS-2728 forms submitted to CMS by dialysis facilities, cross-referenced with patient
record updates through the end of 2010, and tracked through December 2010 in the CMS SIMS registry.
Results: We report a sustained renal recovery (i.e no return to ESRD during the available follow up period) rate
among Medicare ESRD patients of > 5% - much higher than previously reported. Recovery occurred primarily in the
first 2 months post incident dialysis, and was more likely in cases with renal failure secondary to etiologies associated
with acute kidney injury. Patients experiencing sustained recovery were markedly less likely than true long-term
ESRD patients to have permanent vascular accesses in place at incident hemodialysis, while non-White patients,
and patients with any prior nephrology care appeared to have significantly lower rates of renal recovery. We also
found widespread geographic variation in the rates of renal recovery across the United States.
Conclusions: Renal recovery rates in the US Medicare ESRD program are higher than previously reported and
appear to have significant geographic variation. Patients with diagnoses associated with acute kidney injury who are
initiated on long-term hemodialysis have significantly higher rates of renal recovery than the general ESRD
population and lower rates of permanent access placement.
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Introduction
Recovery of renal function in patients requiring prolonged
hemodialysis is thought to be a relatively uncommon
occurrence. Large observational cohorts of patients started on
long term hemodialysis from different parts of the world
reported renal recovery rates of as low as 1%-2.4%[1,2] . Since
2007, the United States Renal Data System(USRDS) has
excluded from its definition of prevalent end stage renal
disease (ESRD) patients who experienced recovery of renal
function occurring within the first 180 days of first ESRD
service and persisting for at least 90 days – and has applied
this definition retroactively[1]. However, during this period of
exclusion, the rate of renal recovery has been estimated, for
the 1995 - 2006 period, to be approximately 0.9% of the ESRD
population and more recent data has suggested a rapid
increase in the rate of recovery in the US ESRD program [3,4].
Smaller cohort studies have suggested slightly higher rates of
recovery among incident peritoneal dialysis patients[5]. A
higher rate is reported in patient cohorts that include a large
percentage of patients who are dialysis-dependent following
acute kidney injury (AKI)[2]. For example, in a recent large
observational cohort of patients admitted to the ICU who
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required renal replacement therapy, 78% of patients
experienced renal recovery within one year[6].
Our primary hypothesis was that sustained recovery of renal
function is more likely to occur with diagnoses that are
associated with AKI. We expected that patients with
temporaryrecovery of renal function— i.e., those who
recovered and later returned to hemodialysis — were likely to
have underlying chronic kidney disease with either progression
that was temporarily reversible or with superimposed acute
kidney injury that improved, and thus were excluded from our
primary analysis. These patients were analyzed as a separate
subgroup of the cohort. We also studied the geographic
variation in the overall rates of renal recovery and the rates of
renal recovery from AKI across the continental United States.
Methods
Data Source and patient cohort
All patients with end stage renal disease who enroll for
Medicare ESRD benefits are required to have an ESRD
Medical Evidence Report (“2728 form”) submitted within 45
days of initiation of therapy by their dialysis or transplant
providers to the Centers for Medicare & Medicaid Services
(CMS)[7]. Physicians completing the form are required to
certify that the patient has “reached the stage of renal
impairment that appears irreversible and permanent and
requires a regular course of dialysis or kidney transplant to
maintain life.” Instructions accompanying the form explicitly
state, “This form SHOULD NOT be completed for those
patients who are in acute renal failure. Acute renal failure is a
condition in which kidney function can be expected to recover
after a short period of dialysis, i.e., several weeks or months.”
[7] We obtained Medicare ESRD registration data from
CMS-2728 forms submitted to CMS by dialysis facilities for
calendar years 2008 and 2009. Data from these forms were
cross-referenced with patient record updates through the end
of 2010 to identify patient status changes due to renal
recovery. Patients who died following initiation of dialysis were
included in our cohort and follow up was censored at the time
of death.
We identified a total of 194,007 incident hemodialysis
patients who were thought to have met the criteria for the
ESRD benefit at the time of registration and began
hemodialysis in 2008 or 2009, and were tracked through
December 31, 2010. CMS contracts with 18 geographically
based ESRD Networks that cover the United States and
territories, to support and improve the quality of care to
beneficiaries in the Medicare ESRD program, interfacing
between ESRD care providers and CMS. The CMS Standard
Information Management System (SIMS) database receives
verified information from the 18 ESRD Networks on a monthly
basis.
Definitions
Sustained Recovery.  Incident ESRD patients registered in
2008 and 2009 in their SIMS registry record, who had recovery
of renal function, as indicated by patient event code “9,” and
did not return for either dialysis or transplantation through the
end of our follow up period of at least one year, and up to three
years, were defined as patients with sustained recovery of
renal function.
Temporary Recovery.  Patients with temporary recovery of
renal function, i.e., those patients with recovery of renal
function who subsequently returned to hemodialysis within our
follow up period, were excluded from our primary analysis of
patients with sustained recovery of renal function. It should be
noted that 2009 incident patients had at least one year where
they were at risk of returning to dialysis, and while this
exposure period is a shorter period than for 2008 incident
patients, both groups had longer periods of return exposure
risk than the 90 days used by the USRDS1.
Statistical Analysis
For univariate analyses, categorical variables were
compared using the chi square test, while continuous variables
were compared using the t test. A multivariable logistic
regression model using patient characteristics that were likely
to be associated with sustained renal recovery including
demographics (age, gender, race), prior nephrology care, type
of dialysis access available primary diagnoses and reported
comorbidities. Statistical analyses and map generation were
performed using Stata 11.2 (Stata Corp., College Station, TX).
Results
In the overall cohort of 194,007 patients initiating
hemodialysis in 2008 and 2009, we identified 12,970 patients
(6.69%) who had evidence of recovery of renal function during
the follow up period (Figure 1) . Of these, 1,916 patients
(14.8%) with evidence of renal recovery returned to dialysis
within the follow-up period (temporary recovery). The rate of
sustained renal recovery was significantly higher in 2009 than
in 2008 (5.9% vs. 5.6%, p=0.01), a difference that persisted
even after exclusion of those patients whose ESRD diagnosis
was acute tubular necrosis (ATN), the most common diagnosis
among those who recovered kidney function. This observation
seems consistent with other analyses that have also suggested
recent rising rates of renal recovery in the US ESRD
program[4]. The rate of sustained recovery showed a similar
increase from 2008 to 2009 after exclusion of all diagnoses
primarily associated with AKI (2009 vs. 2008: 4.4 vs. 4.2%).
Patients with evidence of sustained renal recovery were
younger on average and more likely to be male than individuals
who did not experience any recovery of renal function (Table
1). The racial composition of the groups with and without
sustained recovery differed significantly (Table 1), with a higher
percentage of patients reported as “white” on the CMS-2728
form in the sustained recovery group than in the group without
recovery of renal function. Patients with recovery had similar
overall rates of recovery across types of prior insurance
coverage, although differences were seen with lower rates of
recovery for those covered by Medicare and Medicaid, and
higher rates of recovery for those covered by insurance
through their employer (Table 1).
Patients with recovery of renal function had very low rates of
permanent accesses (arteriovenous fistula or graft) in place or
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awaiting maturation at the time of dialysis initiation. This finding
also supports our acute etiology hypothesis given that it takes
time to place permanent accesses. Similarly, higher usage
rates of catheters (over 96%, from Table 1), which can be more
quickly placed, would be expected for those in whom renal
failure suddenly occurred.
Several diagnoses were associated with a significantly
higher rate of recovery of renal function than the overall rate of
sustained renal recovery (5.75%) including acute interstitial
nephritis (AIN), acute tubular necrosis (ATN), post partum renal
failure, rapidly progressive glomerulonephritis (RPGN),
exposure to analgesics and other nephrotoxic agents,
cholesterol emboli, hepatorenal syndrome (HRS), and
hemolytic uremic syndrome (HUS)(Table 2). ATN alone
accounted for 19.9% of all cases of renal recovery (and 22% of
all cases of sustained recovery), while other diagnoses that are
commonly associated with acute kidney injury - AIN, RPGN,
HRS, HUS, post-infectious glomerulonephritis, cholesterol
emboli, trauma, liver transplant and toxin exposure –
accounted for a further 11.1% of the observed renal recovery
cases. These results strongly support our acute hypothesis.
Overall, patients with recovery were only half as likely to
have received any prior nephrology care (61.6% vs. 30.6% with
rrf). Among those who did receive care from a nephrologist
prior to starting dialysis, patients with recovery of renal function
were less likely to have had long term care (>12 months), and
more likely to have received only recent care (< 6 months)
(Table 1). Both of these findings are consistent with our acute
etiology hypothesis in that acute onset of renal failure is less
likely to afford the necessary time for a specialist referral or
consult, so fewer occur, and when they do occur, their duration
is shorter.
We also found significant variation in the rates of renal
recovery across ESRD Networks and states (Figure 2). The
overall rate of renal recovery varied significantly across ESRD
Networks, ranging from 3.4% (Network 3) to 7.6% (Network 7).
Similarly, there was considerable variation across states, with
rates ranging from 2.5% (Delaware) to 9.6% (Kansas). Of note,
Guam, the Northern Mariana Islands and American Samoa
each had lower rates of renal recovery than Delaware. Further
analysis of the relative distribution of various diagnoses
demonstrated marked geographic variation at the state or
Network level in the rate of renal recovery only for patients with
ATN (Figure 2). For example, while more than a third of cases
of ATN nationwide experienced recovery of renal function,
there was substantial variation among ESRD Networks,
Figure 1.  Histogram showing time to renal recovery for the entire cohort and for those patients with ATN – for those
patients who do have sustained recovery of renal function.  
doi: 10.1371/journal.pone.0083447.g001
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ranging from about a quarter of cases experiencing recovery
(23.5% in Network 3) to almost half of all cases (48% in
Network 13). Sustained recovery of renal function among
patients with ATN varied from 0% (Alaska) to 59.5%
(Oklahoma).
Renal recovery was most likely to occur in the first month
after incident hemodialysis, with more than half the cases of
Table 1. Comparisons of patients without recovery of renal function with those who have evidence of sustained recovery of
renal function as well as that of patients with temporary and sustained recovery of renal function.
Characteristic
ESRD patients without renal
recovery
ESRD patients with sustained
renal recovery p value1
With temporary Renal
Recovery p value2
N 181,037 (94.25%) 11,054 (5.68%)  1916 (0.99%)  
Age (years) 63.9 ± 15.6 62.3 ± 15.6 <0.001 63.4 ± 14.8 0.004
Male (%) 56.5 58.3 <0.001 57.7 0.425
Race      
White (%) 64.6 79.0 <0.001 74.7 <0.001
Black (%) 29.9 18.0  22.6  
Other (%) 5.6 3.0  2.7  
Access at Incident dialysis initiation (%)      
AV fistula (%) 14.8 1.9 <0.001 7.41 <0.001
AV graft (%) 3.39 0.9  1.25  
Catheter (%) 80.9 96.4  90.08  
Other (%) 0.9 0.8  1.25  
Insurance coverage      
Medicaid 11.94 10.27 <0.001 11.06 <0.001
Veterans Affairs 1.09 0.75  1.2  
Medicare 15.1 14.2  16.34  
Medicare advantage 4.97 4.95  5.01  
Medicare and Medicaid 12.4 9.86  11.95  
Medicare & employer based 7.69 7.35  9.19  
Medicare and other 13.75 14.18  14.93  
Employer based 14.19 18.84  13.62  
Other 6.46 7.22  6.78  
Other combinations 4.64 4.17  4.75  
No insurance coverage 7.76 8.21  5.17  
Nephrology care prior to ESRD therapy      
< 6 months (%) 21.1 26.7 <0.001 22.42 <0.001
6 - 12 months (%) 36.4 40.7  38.05  
> 12 months (%) 42.5 29.7  39.52  
Comorbid conditions      
Diabetes (%) 33.57 23.43 <0.001 41.39 <0.001
Hypertension (%) 76.34 65.26 <0.001 76.93 <0.001
Congestive heart failure (%) 29.78 22.08 <0.001 36.95 <0.001
Cerebrovascular accident (%) 8.5 6.59 <0.001 9.19 <0.001
No comorbid conditions reported (%) 0.02 0.1 <0.001 0 0.167
1 Comparison between patients with sustained recovery of renal function and no recovery of renal function
2 Comarpison of patients with temporary and sustained recovery of renal function
doi: 10.1371/journal.pone.0083447.t001
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renal recovery occurring within the first two months, and more
than two thirds in the first 3 months of registration of ESRD
(Figure 1). Rates of recovery for patients with ATN as the
primary cause of renal failure were more rapid, with more than
two-thirds of cases of renal recovery occurring within the first
two months of registration (Figure 1). Kaplan Meier curves for
various diagnoses demonstrate that the vast majority of renal
recovery occurs within the first few months (Figure 3). These
findings of time to recovery, also, strongly support our acute
etiology hypothesis.
The multivariable model demonstrated a significantly lower
likelihood of renal recovery associated with the placement of a
permanent access and among non-white patients (Table 3).
Previous care from a nephrologist for any length of time was
associated with a lower likelihood of recovery - suggesting that
Nephrologist contact was more likely to be associated with
patients experiencing a slower, chronic disease process which
afforded more time at least for long term access planning.
Additionally, a higher likelihood of renal recovery was seen in
patients with a history of toxin exposure (“toxic nephropathy”),
alcohol/drug abuse and among those patients with no other
comorbidities at the time of incident dialysis - findings that are
also consistent with the acute etiology hypothesis.
Discussion
Recovery of renal function among patients requiring
hemodialysis is not rare, with multiple reports in the
literature[1-4]. Rates of recovery among large cohorts are
generally low – in the 1-2% range but there are some
suggestions of increasing rates of recovery within the US
ESRD program[1-4]. While previous estimates of renal
recovery in the Medicare ESRD program were of the same
magnitude our analysis suggests the possibility of an
increasing rate of renal recovery over time, and also indicates
that almost a third of patients who experienced renal recovery
have a primary diagnosis for the cause of renal failure that is
associated with acute kidney injury[4]. However, an acute insult
superimposed on advanced chronic kidney disease could
easily result in renal failure requiring dialysis with little hope for
sustained recovery. We limited our primary analysis to those
patients who experienced recovery of renal failure and did not
return to the ESRD program during the follow up period,
allowing for a more conservative estimate of the rate of
recovery of renal function. Despite this, our analysis suggests a
higher rate of renal recovery in the Medicare ESRD program
than the previously reported 0.9% rate of recovery of renal
function for patients enrolled in the program[8].
Specific primary diagnoses that are usually associated with
acute kidney injury were seen more commonly among
Table 2. Primary renal diagnoses with higher than average percentage of patients with sustained recovery of renal function.
Primary cause of renal failure ESRD patients with sustained renal recovery (%) p value*
Acute interstitial nephritis 42.7 <0.001
Acute tubular necrosis 37.0 <0.001
Postpartum renal failure 31.4 <0.001
Post-infectious glomerulonephritis 30.0 <0.001
Hemolytic uremic syndrome 27.0 <0.001
Nephropathy secondary to heroin/other drugs 24.2 <0.001
Lymphoma of the kidneys 24.2 <0.001
Trauma/surgical loss of kidney 23.5 <0.001
Benign urinary tract tumors 20.0 <0.001
Other nephrotoxic agents 19.1 <0.001
Wegner’s granulomatosis 16.7 <0.001
Cholesterol emboli 15.9 <0.001
Analgesic abuse 15.7 <0.001
Other renal disorders 15.5 <0.001
Rapidly progressive glomerulonephritis 15.0 <0.001
Radiation nephritis 15.0 <0.001
Henoch-Schonlein 14.6 <0.001
Multiple myeloma 14.0 <0.001
Tuberous sclerosis 12.7 <0.001
Hepatorenal syndrome 12.8 <0.001
Complications of liver transplant 10.4 <0.001
Unknown 10.4 <0.001
Scleroderma 9.1 <0.001
SLE nephritis 8.8 <0.001
AIDS nephropathy 8.1 <0.001
*compared to the renal recovery rate in the entire cohort.
doi: 10.1371/journal.pone.0083447.t002
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recovered patients: for example, after diabetes and
hypertension, the most frequent primary diagnoses were
unknown etiology (4.1%) and ATN (3.5%) - which had
sustained renal recovery rates of 10.4% and 37% respectively.
Other diagnoses associated with acute kidney injury that were
included in the top 10 pre-ESRD diagnoses in the cohort
included multiple myeloma (14% sustained recovery) and
“other renal disorders” (15.5% sustained recovery).
Identification of renal recovery for patients receiving
hemodialysis requires careful monitoring on the part of
healthcare providers. Thus, perhaps the increase in rates and
the geographic variation in renal recovery identified in the
Figure 2.  Maps demonstrating the significant geographical variation in the overall rates of renal recovery and the rates
of renal recovery for patients initiated on hemodialysis with a diagnosis of “tubular necrosis”.  
doi: 10.1371/journal.pone.0083447.g002
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Medicare ESRD program may be a reflection of improved
identification of recovery of renal function and improved care
among hemodialysis patients, rather than changes in ESRD
registration patterns. While the dataset precluded us from
being able to test this hypothesis, the extremely low rates of
permanent access placement in patients who experienced
sustained recovery of renal function suggests an expectation of
possible, eventual recovery on the part of the treating physician
– or may perhaps reflect the absence of nephrology care prior
to initiation of chronic hemodialysis. Further, although higher
rates of renal recovery could be a direct reflection of changing
ESRD patient case-mix created by enrolling increasing
percentages of patients with renal failure caused by etiologies
that may be reversible, the significant increase in the rate of
renal recovery in 2009 compared to 2008 persisted even after
exclusion of ATN cases. The rate of renal recovery in 2009
were also marginally higher after exclusion of all the diagnoses
primarily associated with AKI (ATN, AIN, RPGN, HRS, HUS,
post-partum renal failure, trauma, nephrotoxic agents, post-
infectious GN and liver transplant). Therefore, it is possible that
the increasing rate of renal recovery are due to factors related
to improved patient care such as better attention to fluid weight
management and avoidance of intradialytic hypotension,
avoidance of nephrotoxins, and better care of the underlying
illnesses due to advances in pharmacotherapeutics. Patients
who experienced recovery of renal function were also less
likely to have permanent access placed suggesting possible
recognition for the potential for recovery on the part of the
treating physician. As a result, perhaps these patients should
be excluded from prevalence estimates for arteriovenous
fistulas among ESRD patients in the US.
Patients with temporary recovery of renal function were
older, more likely to be Black and more likely to have Medicare,
prior nephrology care, diabetes and hypertension than those
who had sustained reocovery of renal function. Temporary
recovery of renal function is the result of one of two possible
clinical scenarios. Given the differences listed above, the more
likely possibility is that patients with acute kidney injury
superimposed on advanced CKD, are likely to return to dialysis
eventually even if they recover the renal function lost in the
acute setting because of the progressive nature of the
underlying CKD. The other, less likely, possibility is that
Figure 3.  Kaplan Meier curves showing comparison of the rates of sustained recovery of renal function by diagnosis
among Medicare ESRD patients.  
doi: 10.1371/journal.pone.0083447.g003
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patients experience an episode of acute injury requiring dialysis
that is followed by recovery and then a subsequent
independent/unrelated instance of dialysis requiring loss of
renal function.
Table 3. Multivariable model for the odds of sustained renal recovery.
 Odds Ratio Std. Err. z P>|z| 95% Confidence Interval
Age (years) 0.994 0.001 -8.72 0.000 0.993 - 0.995
Gender      
Female Ref     
Male 1.046 0.022 2.12 0.034 1.003 - 1.090
Access      
Non-permanent access Ref     
Permanent access^ 0.253 0.015 -22.84 0.000 0.225 - 0.285
Race      
White or Other Ref     
Black 0.551 0.015 -22.02 0.000 0.523 - 0.581
Primary diagnosis      
Acute interstitial nephritis 8.459 0.800 22.56 0.000 7.027 - 10.182
Acute tubular necrosis 6.469 0.226 53.47 0.000 6.041 - 6.927
Nephropathy * 3.463 0.320 13.43 0.000 2.889 - 4.152
Cholesterol emboli 2.767 0.300 9.38 0.000 2.237 - 3.424
Multiple myeloma 1.837 0.129 8.64 0.000 1.600 - 2.109
Unknown etiology 1.454 0.064 8.54 0.000 1.334 - 1.585
Hepatorenal syndrome 1.289 0.127 2.56 0.010 1.062 - 1.565
Hypertension 0.711 0.023 -10.63 0.000 0.667 - 0.757
Diabetes 0.544 0.017 -19.10 0.000 0.511 -0.579
Nephrology Care      
No prior nephrology care Ref     
Any prior nephrology care 0.374 0.009 -40.72 0.000 0.356
Comorbidities      
Diabetes 0.920 0.025 -3.07 0.002 0.873 - 0.970
Hypertension 0.823 0.019 -8.31 0.000 0.786 - 0.862
COPD 0.933 0.196 -0.33 0.741 0.617 - 1.409
Current smoker 0.876 0.241 -0.48 0.629 0.511 - 1.501
Cancer 1.124 0.208 0.63 0.527 0.782 - 1.614
Toxic nephropathy 7.767 3.975 4.01 0.000 2.849 - 21.180
Alcohol and/or drug abuse 2.315 0.765 2.54 0.011 1.211 - 1.424
Needs assistance** 1.109 0.094 1.22 0.223 0.939 -1.310
Cardiac disease*** 0.817 0.020 -8.43 0.000 0.780 -0.856
No comorbidities reported 2.148 0.828 1.99 0.047 1.010 - 4.571
^. Permanent access refers to mature AV fistula or graft only
*. Nephropathy caused by agents other than lead and analgesics
**. Needs assistance includes institutionalized patients and those needing assistance ambulating and/or transferring
***. Patients with any reported cardiac or vascular disease including congenital heart disease, atherosclerotic heart disease, peripheral vascular disease, cerebrovascular
disease, congestive heart failure and/or other cardiac disease
doi: 10.1371/journal.pone.0083447.t003
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While we are able demonstrate significant variations in state
and ESRD Network level renal recovery rates, the dataset does
not help ascertain if these variations are related to varying
physician decision making thresholds for initiation of
hemodialysis and registration for ESRD benefits, or to
differences in monitoring of patients for evidence of recovery of
renal function among registered ESRD patients receiving
hemodialysis. The inability to provide outpatient maintenance
renal replacement therapy for patients without end stage renal
disease appears to be unique to the United States. This may
have impacted our analysis and may limit the potential
generalizability of our findings to ESRD programs in other
countries particularly to programs in countries with universal
health care coverage.
Conclusions
Rate of recovery of renal function in the Medicare ESRD
program appears to be higher than previously reported and
appear to be increasing over time. There is marked geographic
variation in rates of renal recovery across states and ESRD
Networks, particularly for patients reported to have ATN as the
primary cause of ESRD. Not surprisingly, patients with
diagnoses that are associated with acute kidney injury who are
initiated on long-term hemodialysis have significantly higher
rates of renal recovery than the general ESRD population.
Sustained renal recovery appears to occur predominantly
within the first 3 months of initiation of hemodialysis, and
continues to be seen over the first 12 months, albeit less
frequently. Patients who have recovery of renal function were
also less likely, perhaps appropriately, to have permanent
access placement at the time of initiation of hemodialysis. As a
result, patients with these renal diagnoses at the time of
registration are likely to benefit from closer monitoring of their
residual renal function, interventions to avoid additional renal
injury and periodic reassessment of their need for continued
renal replacement therapy.
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